This medical device material was invested by the giant in a heavy warehouse. New changes in the industry have arrived.

behind the rise of wearablesOn September 16, 2020, at Apple's fall launch, Apple CEO Tim Cook unveiled the next-generation Apple Watch, which features a new blood-oxygen monitoring sensor that can be tested every 15 seconds, a selling point that has caught the eye of fruit powder.Blood oxygen saturation, after a new crown, I believe that everyone is no longer unfamiliar with it, it is an important physiological parameters of the human respiratory cycle, but also a key indicator to measure a person's overall health. It can obtain data by collecting and detecting blood from the patient's arteries, or it can be obtained through pulse oxygen saturation monitoring technology.Wearables are often dependent on high-tech materials for reliable data transmission and comfortable touch, one of the most widely used and well-known materials being silicone materials.Silicone materials are widely used not only in wearable electronics for everyday consumer use, but also in the medical field, where material safety, comfort, dosing and data transmission capabilities are extremely demanding. With the development of intelligent medicine, silicone materials are increasingly used in connected medical devices and wearable medical devices.In the Development Plan for a New Generation of Artificial Intelligence issued by the State Council in 2017, it was clearly stated that the core technology and product development of smart terminals should be accelerated, and product forms and application services such as wearable medical devices should be developed. "Made in China 2025" also made it clear that we should focus on the development of medical robots and other high-performance medical equipment, and actively encourage domestic medical device innovation. In this process, medical silicone materials will play an irreplaceable role.

more than 70 years of medical silicone "old" welcome "new"Silicone materials have been used in the medical industry for a long time and have effectively promoted the development of medical technology and industry. When it comes to head companies with medical silicone technology, many in the industry are no strangers to the original Corning company that ushered in the era of commercialization of silicone technology. With the restructuring of the company in recent years, its medical silicone business is now the healthcare business of DuPont's transportation and industrial division.On September 15, 2020, DuPont introduced a new brand name, DuPont ™ Liveo, for its 70-year-old medical silicone™ solution. In the field of medical devices, Liveo™ has a rich history of innovation: in 1950, defoulants for latex gloves were introduced, and inin 1959, the first hydrocephalus-based hydrostory based on silicone tubes was introduced;1970-1980, medical silicone pressure-sensitive adhesives for permeable patches were commercialized;flexible skin adhesives for advanced wound treatment were invented in 1990; and 2021, innovative skin adhesive technologies for wearable medical devices ..."Liveo™'s brand is inspired by 'live' and 'live' and 'tobe alive'," says Jennifer Gemo, Global Strategy Marketing Director, DuPont Liveo ™. As a new name for the oldest medical silicone of the original Dow Corning Company, Liveo ™ represents smarter medical solutions and more positive outcomes.Focus on new demand for connected medical devices, re-position innovative investmentsIn recent years, as the population ages and health care costs increase, the global healthcare market needs more patient-centric solutions to successfully complete the value shift from disease treatment to disease prevention. The rise of connected medical devices, wearable medical devices, and health data services provides the basis for timely care and telemedicure based on real-time patient data.In order to gain a competitive advantage in this new round of industry upgrading opportunities, medical device manufacturers are generally facing great pressure to reduce costs. In addition, as regulatory oversight increases and patients demand better medical experiences, businesses are being pushed to find safer, greener, more comfortable and more aesthetic material solutions.DuPont's healthcare business keeps up with intelligent trends and customer needs in the medical device industry, providing safe, comfortable, convenient and effective diagnosis, monitoring and treatment for timely care through a wide range of specialty medical adhesives and elastomer products to support the development trend of connected and wearable devices and enhance the patient experience.Ms Jennifer Gemo added: "Liveo ™ will replace the Dow Corning ™ and SILASTIC™ brand names already on the market, but the product and packaging materials have not changed. All plants will continue to produce the same products using the same rigorous processes and quality control systems as in the past. Liveo™ was born not only as a name change, but also as a sign that DuPont will continue to deliver more than 70 years of innovative development capabilities, regulations and production experience, as well as applying expertise and invigorate it to focus more on driving healthcare.In addition, DuPont continues to invest more in innovation to further strengthen its strategic capabilities and help customers consolidate their market leadership. In the medical device sector, DuPont's investment focuses on: . Increase the production capacity of silicone elastomers, including liquid silicone rubber (LSR) and solid silicone rubber (HCR)These products can be used in connected medical devices (e.g. monitoring and diagnostic equipment), special equipment (e.g. respiratory devices), long-term or short-term implants, as well as advanced wound care, fistula care, etc.

to work closely together to accurately empower our partners to develop newIn the past two decades, the Chinese market has become one of the most critical markets for the world's major companies, and DuPont ™Liveo™ has made the Chinese market its strategic focus."In this process, we will have innovative products coming out and working more closely with customers in the medical device industry, including companies that make wearables," says Jennifer Gemo. "In Jennifer's view, DuPont's medical silicone adhesives, elastomers, and some surface or skin treatment solutions will provide greater support for medical device production.Referring to expectations for the Chinese market, Zhang Xin, Director of Healthcare Asia Pacific at DuPont Transportation and Industry, said: "DuPont hopes to continue to be a preferred silicone solution provider for healthcare customers for the next three to five years and continue to grow at double-digit annual rates.In order to achieve this goal, DuPont Transportation and Industry Division Medical Health Asia Pacific Technical Director Lu Jian said: "DuPont will continue to strengthen communication and cooperation with the domestic medical device industry head enterprises, more mature silicone application cases abroad to domestic enterprises, to help domestic enterprises broaden the scope of product use." " in addition, DuPont will expand its China business team, leveraging expertise, innovation, advanced production lines and high-performance materials, working with processors, assemblers, design companies and OEMs to develop new products for medical device customers in all aspects of design, research and development, production, etc. Lu Jian added.In addition to medical devices, DuPont ™Liveo™ provides customers with pharmaceutical-grade silicone tubes and molded components in the field of biopharmaceutical processes and pharmaceutical solutions, as well as unique external, transderferment solutions and gastrointestinal active pharmaceutical ingredients (APIs) for safe, cost-effective production of biologics such as innovative drugs and vaccines and antibodies, and provides safe and effective pathways for the transmission of new therapeutic drugs. (Cypress Blue Equipment)